Psychopharmacological treatment in the pre-clinical emergency medicine;Psychopharmakotherapie im notarztdienst

Anaesthesist

Volumn 52, Issue 7, 2003, Pages 577-585

  Pajonk, F G ^a   Fleiter, B ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Antipsychotics; Benzodiazepines; Crisis intervention; Pharmacological treatment; Pre clinical emergency medicine; Psychiatric emergencies; Rapid tranquilisation

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; HALOPERIDOL; LEVOMEPROMAZINE; LORAZEPAM; MIDAZOLAM; MIDAZOLAM MALEATE; NEUROLEPTIC AGENT; OLANZAPINE; PROMETHAZINE; RISPERIDONE; TRIFLUPROMAZINE; ZIPRASIDONE;

AGITATION; ALGORITHM; ANXIETY DISORDER; ARTICLE; CRISIS INTERVENTION; DATA ANALYSIS; DELIRIUM; DOSE CALCULATION; DRUG EFFICACY; DRUG TOLERABILITY; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICINE; EVIDENCE BASED MEDICINE; HUMAN; MANIA; MEDICAL INFORMATICS; MEDICAL LITERATURE; MENTAL DISEASE; NEUROSIS; PRACTICE GUIDELINE; PSYCHOPHARMACOLOGY; PSYCHOSIS; REACTIVE DEPRESSION; RESTLESSNESS; SCHIZOPHRENIA; SOMATIZATION; TREATMENT INDICATION;

ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; EMERGENCY MEDICAL SERVICES; HUMANS; MENTAL DISORDERS; PSYCHOTROPIC DRUGS;

EID: 0042235428     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-003-0549-0     Document Type: Article

References (74)

1. Aleman A, Kahn RS (2001) Effects of the atypic antipsychotic risperidone on hostility and aggression in schizophrenia: A meta-analysis of controlled trials. Eur Neuropsychopharm 11:289-293
2. Atakan Z, Davies T (1997) ABC of mental health. Mental health emergencies. BMJ 314:1740-1742
3. Barbee JG, Mancuso DM, Freed Cr, Todorov AA (1992) Aprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia. Am J Psychiatry 149:506-510
4. Barr J, Zomorodi K, Bertaccini EJ, Sharer SL, Geller E (2001) A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology 95:286-298
5. Baust W (1983) Klinische Aspekte zur Beurteilung von Schlafmitteln. Int Welt 2:51-56
6. Benkert O, Hippius H (1996) Psychiatrische Pharmakotherapie, 6. Aufl. Springer, Berlin Heidelberg New York
7. Benkert O, Hippius H (2003) Kompendium der psychiatrischen Pharmakotherapie, 4. Aufl. Springer, Berlin Heidelberg New York
8. Berkowitz JM (1978) A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology. J Clin Psychiatry 39:46-52
9. Berzewsky H (1996) Der psychiatrische Notfall, 2. Aufl. Springer, Berlin Heidelberg New York
10. Bieniek SA, Ownby RL, Penalver A, Dominguez RA (1998) A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 18:57-62
11. Braun J, Preuss R (1998) Klinikleitfaden Intensivmedizin, 4. Aufl. Gustav Fischer, Lübeck
12. Breier A, Meehan K, Birkett M et al (2002) A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 59:441-8
13. Brook S, Lucey JV, Gunn KP (2000) Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group. J Clin Psychiatry 61:933-41
14. Carriere P, Bonhomme D, Lemperiere T (2000) Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group). Eur Psychiatry 15:321-9
15. Cavanaugh 5V (1986) Psychiatric emergencies. Med Clin North Am 70:1185-1202
16. Cernaianu AC, DelRossi AJ, Flum DR et al (1996) Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost. Crit Care Med 24:222-228
17. Clinton JE, Sterner S, Stelmachers Z, Ruiz E (1987) Haloperidol for sedation of disruptive emergency patients. Ann Emerg Med 16:319-22
18. Currier GW (2000) Atypical antipsychotic medications in the psychiatric emergency service. J Clin Psychiatry 61 (Suppl 14):21-26
19. Currier GW, Simpson GM (2001) Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychiotic agitation. J Clin Psychiatry 62:153-157
20. Daniel DG, Potkin SG, Reeves KR, Swift RH, Harrigan EP (2001) Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology 155:128-134
21. Derlet RW, Albertson TE, Rice P (1989) The effect of haloperidol in cocaine and amphetamine intoxication. J Emerg Med 7;633-637
22. Dick WF (2002) Brauchen wir noch einen Notarzt oder brauchen wir einen anderen Notarzt? Gedanken zu einer aktuellen Entwicklung. Notfall & Rettungsmedizin 5:138-141
23. Dick WF (2002) Notarzt oder KV-Arzt? - Die Aufgabe in der präklinischen Medizin. Notfall & Rettungsmedizin 5:572-573
24. Dubin WR, Feld JA (1989) Rapid tranquilization of the violent patient. Am J Emerg Med 7:313-320
25. Dubin WR, Weiss KJ, Dorn JM (1986) Pharmacotherapy of psychiatric emergencies. J Clin Psychopharmacol 6:210-22
26. Dudley DL, Rowlett DB, Loebel PJ (1979) Emergency use of intravenous haloperidol. Gen Hosp Psychiatry 1:240-246
27. Ellison JM (1985) Emergency treatment of acute psychosis, agitation and anxiety. Hosp Community Psychiatry 36:351-352
28. Evans L (1977) The role of drug therapy in emergency psychiatry. Aust Fam Physican 6:1039-1043
29. Extein I (1980) Psychopharmacology in psychiatric emergencies. Int J Psychiatry Med 10:189-204
30. Finkel S (1978) Anti-anxiety effects of lorazepam in patients with cardiovascular symptomatology. J Clin Psychiatry 39:35-40
31. Foster S, Kessel J, Berman ME, Simpson GM (1997) Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting. Int Clin Psychopharmacol 12:175-9
32. Fragen RJ (1997) Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units. Clin Ther 19:405-419
33. Gamble JA, Dundee JW, Assaf RA (1975) Plasma diazepam levels after single dose oral and intramuscular administration. Anaesthesia 30:164-169
34. Goldney RD, Spence ND, J.A. B (1986) The safe use of high dose neuroleptics in a psychiatric intensive care unit. Aust N Z J Psychiatry 20:370-375
35. Greenblatt DJ, Shader RI, Franke K et al (1979) Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci 68:57-63
36. Gunasekara NS, Spencer CM, Keating GM (2002) Spotlight on ziprasidone in schizophrenia and schizoaffective disorder. CNS Drugs 16:645-52
37. Harder A (1978) Die gleichzeitige Anwendung von Haloperidol und Lorazepam bei der Behandlung agitierter Psychosen. Pharmatherapeutica 2:1-7
38. Jones B, Taylor CC, Meehan K (2001) The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms. J Clin Psychiatry 62 (Suppl 2):22-24
39. Jusic N, Lader M (1994) Post-mortem antipsychotic drug concentrations and unexplained deaths. Br J Psychiatry 165:787-791
40. Ketai R (1975) Psychotropic drugs in the management of psychiatric emergencies. Postgrad Med 58:87-93
41. König E, Petersdorff T, von Hippel C, Kaschka WP (1999) Zur Erstversorgung psychiatrischer Notfallpatienten. Anaesthesist 48:542-548
42. Lapierre YD, Zajecka JM, Swift RH, Reeves KR, Harrigan EP (2001) Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. Int Clin Pharmacol Biopharm 11:315-322
43. Lesem MD, Zajecka JM, Swift RH, Reeves KR, Harrigan EP (2001) Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry 62:12-18
44. Luiz T, Huber T, Schieth B, Madler C (2000) Einsatzrealität eines städtischen Notarztdienstes: Medizinisches Spektrum und lokale Einsatzverteilung. Anaesthesiologie & Intensivmedizin 41:765-773
45. Madler C (2002) Notarzt und Sozialnot. Notfall & Rettungsmedizin 5:491
46. McAllister-Willliams RH, Ferrier IN (2002) Rapid tranquillisation: time for a reappraisal of options for patenteral therapy. Br J Psychiatry 180:485-489
47. Meehan K, Zhang F, David S et al (2001) A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 21:389-397
48. Menninger WW (1993) Management of the aggressive and dangerous patient. Bull Menninger Clin 57:208-217
49. Meusert W (1971) Prüfung von Lorazepam in der nervenärztlichen Praxis. Arzneimittelforschung 21:1087-1090
50. Moffet AU, Scott DF (1984) Stress and epilepsy. The value of a benzodiazepin - lorazepam. J Neurol Neurosurg Psychiatry 47:165-167
51. Möller HJ (2000) Aktuelle Bewertung neuer/atypischer Neuroleptika. Nervenarzt 71:329-344
52. Möller HJ, Kissling W, Lang C, Doerr P, Pirke K-M, von Zerssen D (1982) Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration. Am J Psychiatry 139:1571-1579
53. Mutschler E (2001) Arzneimittelwirkungen. Lehrbuch der Pharmakologie und Toxikologie, 8. Aufl. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
54. Pajonk FG, Bartels HH, Biberthaler P, Moecke H (2001) Der psychiatrische Notfall im Rettungsdienst - Häufigkeit, Versorgung und Beurteilung dutch Notärzte und Rettungsdienstpersonal. Nervenarzt 72:685-692
55. Pajonk FG, Biberthaler P, Cordes O, Moecke HP (1998) Psychiatrische Notfälle aus der Sicht von Notärzten. Anaesthesist 47:588-594
56. Pajonk FG, Grünberg KAS, Paschen H-R, Moecke H (2001) Psychiatrische Noffälle im Notarztdienst einer deutschen Großstadt. Fortsch ritte der Neurologie Psychiatrie 69:170-174
57. Pajonk FG, Schreiner A, Peters S, Rettig K, Degner D, Rüther E (2003) Initialtherapie mit Risperidon in der Akutbehandlung schizophrener Ratienten - eine Interimsanalyse. Fortschr Neurol Psychiatr 71:249-254
58. Pajonk FG, Volz HP (2003) Akuttherapie schizophrener Patienten, 1. Aufl. Thieme, Stuttgart, 5 30-35
59. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355:1048-1052
60. Remington G, Pollock P, Volneskos G, Warsh J, Reed K, Beresford J, Coulter K (1985) The treatment of acutely psychiatric patients: Clinical and pharmacological correlates. 4. World Congress of Biological Psychiatry, Philadelphia, p 274
61. Resnick M, Burton BT (1984) Droperidol vs. haloperidol in the initial mangement of acutely agitated patients. J Clin Psychiatry 45:198-199
62. Ritter RM, Davidson DE (1971) Haloperidol for acute psychiatric emergencies: A double-blind comparison with perphenazine in acute alcoholic psychosis. South Med J 64:249-250
63. Salzman C, Solomon D, Miyawaki E, Glassman R, Rood L, Flowers, Thayer S (1991) Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. J Clin Psychiatry 52:177-180
64. Schmitt TK, Pajonk F.G., Poloczek S (2000) Psychiatrische Notfälle und Xrisen - Psychische Erste Hilfe, Krisenintervention und Notfallseelsorge. Notfall & Rettungsmedizin 3:531-538
65. Seeler W, Wittgens R (1989) Psychiatrische Akutbehandlung. Fin klinischer Erfahrungsbericht mit Lorazepam pro injectione. Neurologie und Psychiatrie 3:309-310
66. Seffin P, Blumberg D, Otremba W (1991) Arzneimittel im Rettungsdienst. Der Notarzt 7:44-50
67. Silverstein S, Frommer D.A., Marx J.A., Rosen P. (1986) Parenteral haloperidol in combative patients: A prospective study. Ann Emerg Med 15:636
68. Sim M (1975) Psychosomatic conditions in general practice: a double-blind contolted therapeutic trial of lorazepam vs. medazepam. Br J Clin Pract 29:304-306
69. Thomas H, Jr., Schwartz E, Petrilli R (1992) Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Ann Emerg Med 21:407-13
70. Trimble MR (1983) Benzodiazepines divided. A multidisciplinary review. John Wiley & Sons, Chichester
71. Walker JE, Homan RW, Crawford IL (1984) Lorazepam: A controlled trial in patients with intractable partial complex seizures. Epilepsia 25:464-466
72. Weiss JMA (1973) Psychiatric emergendes. Drug Therapy 3:70-72
73. Wright P, Birkett M, David SR et al (2001) Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 158:1149-51
74. Young CC, Prielipp RC (2001) Benzodiazepines in the intensive care unit. Crit Care Clin 17:843-862